[4-(Chloromethyl)phenyl]-phenylmethanone, 95%, 10g

Tris(4-biphenylyl)amine>98.0%(HPLC)1g

1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1), 98%, 25g

1,2-Diphenylpyrazolidine-3,5-dione, 95.0%, 5g

Parecoxib>97.0%(HPLC)(T)250mg

Methyl 2-fluoro-2-methylpropanoate, 95.0%, 25g

Styrene, min. 99.5%, for synthesis, stab., 2.5 l, glass packaging

1-[(2,6-difluorophenyl)methyl]-1,4-diazepane, 95.0%, 2g

5-Bromo-4-isopropylthiazole, 95+%, 1g

1-[4-(prop-2-yn-1-yloxy)phenyl]ethan-1-ol, 95%, 5g

4-BROMO-2-IODO-5-METHYLANILINE, 95.0%, 10g

(R)-2-((tert-Butoxycarbonyl)amino)-3-cyclobutylpropanoic acid, 95+%, 25g

Iron(II) chloride, 98.0%, 25g